// App-Quantinova.ai

TCT-201 : Incidence and Implications of Presentation With Ventricular Tachycardia or Fibrillation in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial

Researchers

Presenter

  • Monica Embacher

Principal Investigators

  • Ioanna Kosmidou

  • Jose Dizon

  • Bjorn Redfors

  • Rushad Dordi

  • Roxana Mehran

  • Ori Ben-Yehuda

  • Gregg Stone

Medical Centers

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Cardiovascular Research Foundation, New York, United States

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Cardiovascular Research Foundation, Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, United States

  • Cardiovascular Research Foundation and Columbia University Medical Center, New York, United States

  • CUMC, New York, New York, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Arrhythmia

  • Ventricular arrhythmias

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim